Home > > > Report Detail

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Equine Pharmaceuticals and Supplements Market 2018, Forecast to 2023

Publisher Name :
Date: 07-Jan-2019
No. of pages: 129

Governments and various animal health institutions spread awareness about the need for good healthy diets and health supplements for the growth and healthy life of the horses among the horse breeders and trainers in various equine industries. Moreover, they provide information and awareness about the need for prevention of certain diseases and the remedy for some medical conditions. Increasing awareness about equine pharmaceuticals and supplements products is driving the growth of the global equine pharmaceuticals and supplements market. Demand for herbal digestive, feed, and energy supplements for horses are increasing due to the preference among horse breeders and trainers for natural products and it is expected to drive the growth of the pharmaceuticals and supplements market. The horseracing and equestrian sectors drive the demand for equine pharmaceutical products, as the health of the horses are very important for sustaining the growth of those sectors. Healthy horses in these sectors provide the impetus for the betting and gambling industries related to horse racing. Therefore, most of the trainers and breeders of horses adopt advanced pharmaceutical products for preventing illnesses and for healing the diseases, so that the horses are in good shape for the races.

Scope of the Report:

This report focuses on the Equine Pharmaceuticals and Supplements in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Equine Pharmaceuticals and Supplements is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Affymetrix

- Bayer Animal Health

- Boehringer Ingelheim

- Celltrion Inc

- Elanco Animal Health

- Merck Animal Health

- Merial

- Novartis Animal Health

- Vetoquinol

- Zoetis

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Pharmaceuticals

- Supplements

Market Segment by Applications, can be divided into

- Veterinary Hospitals

- Drug Stores

- Others

There are 15 Chapters to deeply display the global Equine Pharmaceuticals and Supplements market.

Chapter 1, to describe Equine Pharmaceuticals and Supplements Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Equine Pharmaceuticals and Supplements, with sales, revenue, and price of Equine Pharmaceuticals and Supplements, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Equine Pharmaceuticals and Supplements, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Equine Pharmaceuticals and Supplements Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Equine Pharmaceuticals and Supplements Introduction
1.2 Market Analysis by Type
1.2.1 Pharmaceuticals
1.2.2 Supplements
1.3 Market Analysis by Applications
1.3.1 Veterinary Hospitals
1.3.2 Drug Stores
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Affymetrix
2.1.1 Business Overview
2.1.1.1 Affymetrix Description
2.1.1.2 Affymetrix Headquarter, Main Business and Finance Overview
2.1.2 Affymetrix Equine Pharmaceuticals and Supplements Product Introduction
2.1.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.1.2.2 Equine Pharmaceuticals and Supplements Product Information
2.1.3 Affymetrix Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Affymetrix Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Affymetrix Equine Pharmaceuticals and Supplements Market Share in 2017
2.2 Bayer Animal Health
2.2.1 Business Overview
2.2.1.1 Bayer Animal Health Description
2.2.1.2 Bayer Animal Health Headquarter, Main Business and Finance Overview
2.2.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Introduction
2.2.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.2.2.2 Equine Pharmaceuticals and Supplements Product Information
2.2.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Bayer Animal Health Equine Pharmaceuticals and Supplements Market Share in 2017
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.1.1 Boehringer Ingelheim Description
2.3.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.3.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Introduction
2.3.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.3.2.2 Equine Pharmaceuticals and Supplements Product Information
2.3.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Boehringer Ingelheim Equine Pharmaceuticals and Supplements Market Share in 2017
2.4 Celltrion Inc
2.4.1 Business Overview
2.4.1.1 Celltrion Inc Description
2.4.1.2 Celltrion Inc Headquarter, Main Business and Finance Overview
2.4.2 Celltrion Inc Equine Pharmaceuticals and Supplements Product Introduction
2.4.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.4.2.2 Equine Pharmaceuticals and Supplements Product Information
2.4.3 Celltrion Inc Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Celltrion Inc Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Celltrion Inc Equine Pharmaceuticals and Supplements Market Share in 2017
2.5 Elanco Animal Health
2.5.1 Business Overview
2.5.1.1 Elanco Animal Health Description
2.5.1.2 Elanco Animal Health Headquarter, Main Business and Finance Overview
2.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Introduction
2.5.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.5.2.2 Equine Pharmaceuticals and Supplements Product Information
2.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Elanco Animal Health Equine Pharmaceuticals and Supplements Market Share in 2017
2.6 Merck Animal Health
2.6.1 Business Overview
2.6.1.1 Merck Animal Health Description
2.6.1.2 Merck Animal Health Headquarter, Main Business and Finance Overview
2.6.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Introduction
2.6.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.6.2.2 Equine Pharmaceuticals and Supplements Product Information
2.6.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Merck Animal Health Equine Pharmaceuticals and Supplements Market Share in 2017
2.7 Merial
2.7.1 Business Overview
2.7.1.1 Merial Description
2.7.1.2 Merial Headquarter, Main Business and Finance Overview
2.7.2 Merial Equine Pharmaceuticals and Supplements Product Introduction
2.7.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.7.2.2 Equine Pharmaceuticals and Supplements Product Information
2.7.3 Merial Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Merial Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Merial Equine Pharmaceuticals and Supplements Market Share in 2017
2.8 Novartis Animal Health
2.8.1 Business Overview
2.8.1.1 Novartis Animal Health Description
2.8.1.2 Novartis Animal Health Headquarter, Main Business and Finance Overview
2.8.2 Novartis Animal Health Equine Pharmaceuticals and Supplements Product Introduction
2.8.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.8.2.2 Equine Pharmaceuticals and Supplements Product Information
2.8.3 Novartis Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Novartis Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Novartis Animal Health Equine Pharmaceuticals and Supplements Market Share in 2017
2.9 Vetoquinol
2.9.1 Business Overview
2.9.1.1 Vetoquinol Description
2.9.1.2 Vetoquinol Headquarter, Main Business and Finance Overview
2.9.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Introduction
2.9.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.9.2.2 Equine Pharmaceuticals and Supplements Product Information
2.9.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Vetoquinol Equine Pharmaceuticals and Supplements Market Share in 2017
2.10 Zoetis
2.10.1 Business Overview
2.10.1.1 Zoetis Description
2.10.1.2 Zoetis Headquarter, Main Business and Finance Overview
2.10.2 Zoetis Equine Pharmaceuticals and Supplements Product Introduction
2.10.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
2.10.2.2 Equine Pharmaceuticals and Supplements Product Information
2.10.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Zoetis Equine Pharmaceuticals and Supplements Market Share in 2017
3 Global Equine Pharmaceuticals and Supplements Market Competition, by Manufacturer
3.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Equine Pharmaceuticals and Supplements Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2017
3.4.2 Top 5 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Equine Pharmaceuticals and Supplements Market Analysis by Regions
4.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Regions
4.1.1 Global Equine Pharmaceuticals and Supplements Sales by Regions (2013-2018)
4.1.2 Global Equine Pharmaceuticals and Supplements Revenue by Regions (2013-2018)
4.2 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
5 North America Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers
5.1 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
5.1.1 North America Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
5.1.2 North America Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
5.1.3 United States Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
5.1.4 Canada Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
5.1.5 Mexico Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
5.2 North America Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
5.2.2 North America Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
5.3 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
5.3.2 North America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
5.4 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
5.4.2 North America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)
6 Europe Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers
6.1 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
6.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
6.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
6.1.3 Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.1.4 UK Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.1.5 France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.1.6 Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.1.7 Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
6.2 Europe Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
6.2.2 Europe Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
6.3 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
7.1.3 China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.1.4 Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.1.5 Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.1.6 India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)
8 South America Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers
8.1 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
8.1.1 South America Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
8.1.2 South America Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
8.1.3 Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
8.1.4 Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
8.1.5 Colombia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
8.2 South America Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
8.2.2 South America Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
8.3 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
8.3.2 South America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
8.4 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
8.4.2 South America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.1.4 UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.1.5 Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.1.7 South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)
10 Global Equine Pharmaceuticals and Supplements Market Segment by Type
10.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Type (2013-2018)
10.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2013-2018)
10.2 Pharmaceuticals Sales Growth and Price
10.2.1 Global Pharmaceuticals Sales Growth (2013-2018)
10.2.2 Global Pharmaceuticals Price (2013-2018)
10.3 Supplements Sales Growth and Price
10.3.1 Global Supplements Sales Growth (2013-2018)
10.3.2 Global Supplements Price (2013-2018)
11 Global Equine Pharmaceuticals and Supplements Market Segment by Application
11.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2013-2018)
11.2 Veterinary Hospitals Sales Growth (2013-2018)
11.3 Drug Stores Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2018-2023)
12.2 Equine Pharmaceuticals and Supplements Market Forecast by Regions (2018-2023)
12.2.1 North America Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.2.2 Europe Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.2.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.2.4 South America Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.2.5 Middle East and Africa Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
12.3 Equine Pharmaceuticals and Supplements Market Forecast by Type (2018-2023)
12.3.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2018-2023)
12.3.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2018-2023)
12.4 Equine Pharmaceuticals and Supplements Market Forecast by Application (2018-2023)
12.4.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2018-2023)
12.4.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Equine Pharmaceuticals and Supplements Picture
Table Product Specifications of Equine Pharmaceuticals and Supplements
Figure Global Equine Pharmaceuticals and Supplements CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Equine Pharmaceuticals and Supplements CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Equine Pharmaceuticals and Supplements by Types in 2017
Figure Pharmaceuticals Picture
Table Major Manufacturers of Pharmaceuticals
Figure Supplements Picture
Table Major Manufacturers of Supplements
Figure Equine Pharmaceuticals and Supplements Sales Market Share by Applications in 2017
Figure Veterinary Hospitals Picture
Figure Drug Stores Picture
Figure Others Picture
Figure United States Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure France Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure UK Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure China Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure India Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2013-2023)
Table Affymetrix Headquarter, Established, Main Business and Finance Overview (2017)
Table Affymetrix Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Affymetrix Equine Pharmaceuticals and Supplements Product
Table Affymetrix Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Affymetrix Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Affymetrix Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Bayer Animal Health Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer Animal Health Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Bayer Animal Health Equine Pharmaceuticals and Supplements Product
Table Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer Animal Health Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product
Table Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Celltrion Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Celltrion Inc Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Celltrion Inc Equine Pharmaceuticals and Supplements Product
Table Celltrion Inc Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celltrion Inc Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Celltrion Inc Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Elanco Animal Health Headquarter, Established, Main Business and Finance Overview (2017)
Table Elanco Animal Health Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Elanco Animal Health Equine Pharmaceuticals and Supplements Product
Table Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Elanco Animal Health Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Merck Animal Health Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Animal Health Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Merck Animal Health Equine Pharmaceuticals and Supplements Product
Table Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Animal Health Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Merck Animal Health Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Merial Headquarter, Established, Main Business and Finance Overview (2017)
Table Merial Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Merial Equine Pharmaceuticals and Supplements Product
Table Merial Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merial Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Merial Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Novartis Animal Health Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Animal Health Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Novartis Animal Health Equine Pharmaceuticals and Supplements Product
Table Novartis Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Animal Health Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Novartis Animal Health Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Vetoquinol Headquarter, Established, Main Business and Finance Overview (2017)
Table Vetoquinol Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Vetoquinol Equine Pharmaceuticals and Supplements Product
Table Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Vetoquinol Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Vetoquinol Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Zoetis Headquarter, Established, Main Business and Finance Overview (2017)
Table Zoetis Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
Table Zoetis Equine Pharmaceuticals and Supplements Product
Table Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Zoetis Equine Pharmaceuticals and Supplements Sales Market Share in 2017
Figure Global Zoetis Equine Pharmaceuticals and Supplements Revenue Market Share in 2017
Table Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2016-2017)
Figure Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturer in 2016
Figure Global Equine Pharmaceuticals and Supplements Sale
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs